Back

Heavy chain-1 of inter-α-inhibitor has an integrin-like structure with immune regulatory activities

Briggs, D. J.; Langford-Smith, A. W. W.; Jowitt, T. A.; Kielty, C. M.; Enghild, J. J.; Baldock, C.; Milner, C. M.; Day, A. J.

2019-07-08 biochemistry
10.1101/695700 bioRxiv
Show abstract

Inter--inhibitor (II) is a proteoglycan essential for mammalian reproduction that also plays a less well-characterised role in inflammation. II is composed of 2 homologous heavy chains (HC1 and HC2) covalently attached to chondroitin sulphate on the bikunin core protein. Prior to ovulation HCs are transferred onto the polysaccharide hyaluronan (HA), thereby stabilising a matrix that is required for fertilisation. Here we show that human HC1 has a structure similar to integrin {beta}-chains and contains a functional MIDAS (metal ion-dependent adhesion site) motif that can mediate self-association of heavy chains, providing a mechanism for matrix crosslinking. Surprisingly, its interaction with RGD-containing integrin ligands, such as vitronectin and the latency-associated peptides of TGF{beta}, occurs in a MIDAS/cation-independent manner. However, HC1 utilises its MIDAS motif to bind to, and inhibit the cleavage of, complement C3, thus identifying it as a novel regulator of innate immunity through inhibition of the alternative pathway C3 convertase.\n\nAbbreviationsADPs, atomic displacement parameter; AUC, analytical ultracentrifugation; CMG2, capillary morphogenesis protein-2; COC, cumulus-oocyte complex; CS, chondroitin sulphate; FB, complement factor B; FnIII; fibronectin type III; HA, hyaluronan; HC, heavy chain; HC*HA, covalent complex of HC with HA; II, inter--inhibitor; ITGA, integrin -chain; ITGB, integrin {beta}-chain; LAP, latency associated peptide; LLC, large latent complex; LTBP, latent TGF{beta} binding protein; MIDAS, metal ion-dependent adhesion site; PI, pre--inhibitor; PTX3, pentraxin-3; rHC1, recombinant HC1; SAXS, small-angle X-ray scattering; SHAP, serum-derived HA binding protein; SLC, small latent complex; TEM8, tumour endothelial marker-8; TGF{beta}, transforming factor {beta}; TSG-6, tumour necrosis factor-stimulated gene-6; TSG-6*HC, covalent complex of TSG-6 and HC; vWFA domain, von Willebrand Factor A domain.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.